Back to News Back to News

Related Posts

26Jan

Bridging global kidney care gaps through data: KI presents ISN-GKHA Interactive Map   

A recent Kidney International® editorial showcases the ISN-Global Kidney Health Atlas (ISN-GKHA) Interactive Map, an open-access tool... read more

12Jan

“Stay on top of the evidence base” — Adeera Levin on WCN’26 HIT sessions 

At WCN’26, the high-impact trials (HIT) and late-breaking clinical trials (LBCT) sessions will show you what matters most for patient... read more

08Dec

Research in action: How ISN committees are driving the future of kidney research — and how you can be part of it 

Across the ISN’s research groups and committees, this year has been... read more

08Dec

Rethinking kidney trials: The ISN’s PARADIGM roadmap moves into action 

  Kidney disease research is entering a pivotal moment. Kidney International®  published... read more

27Oct

ISN Journal summaries on felzartamab for IgA nephropathy and a new anti-podocin ELISA  

Kidney International®   Randomized, double-blind, placebo-controlled phase 2a study assessing the efficacy and... read more

13Oct

ISN Journal summaries on the DIALIZE-Outcomes trial and heat stress nephropathy in CKDu hotspots in India 

Kidney International®   The randomized DIALIZE-Outcomes trial evaluated sodium zirconium cyclosilicate in hemodialysis  People... read more

15Sep

CONFIDENCE trial: Dual therapy shows promise for CKD and diabetes  

ISN-ACT Global Trials Focus (GTF) editorial team member Michele Provenzano summarizes... read more

01Sep

Building momentum in CKDu research: Global experts share progress and insights 

The mystery of chronic kidney disease of unknown origin (CKDu) continues... read more

28Jul

From data to impact: What is it like to be part of ISN research initiatives? 

From global policy tools to community-driven projects and early-career development, ISN's... read more

30Jun

Explore the latest ISN Global Trials Focus selections featuring a “Trial of the month” on the effect of dapagliflozin in patients with ADPKD receiving tolvaptan

ISN-ACT Global Trials Focus editorial team member Michele Provenzano summarizes the design... read more